Page last updated: 2024-11-01

norfloxacin and Lymphoma

norfloxacin has been researched along with Lymphoma in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carratala, J1
Fernandez-Sevilla, A1
Tubau, F1
Dominguez, MA1
Gudiol, F1
De Beule, F1
Bercy, P1
Ferrant, A1

Other Studies

2 other studies available for norfloxacin and Lymphoma

ArticleYear
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; DNA, Bacterial; Drug Resistance, Micr

1996
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
    Journal of clinical periodontology, 1991, Volume: 18, Issue:5

    Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Imm

1991